Australia markets open in 39 minutes

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.11+1.42 (+3.25%)
At close: 04:00PM EDT
45.99 +0.88 (+1.95%)
After hours: 04:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts17171919
Avg. Estimate-1.75-1.64-6.44-5.02
Low estimate-2.04-2.01-8.32-7.05
High estimate-1.39-1.36-5.23-1.58
Year ago EPS-2.33-2.25-8.25-6.44
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151819
Avg. Estimate116.3M125.25M513.08M642.62M
Low estimate98.8M120.38M499.73M541.73M
High estimate124.6M130.1M530.01M920.7M
Year ago sales100.5M108.31M434.25M513.08M
Sales growth (year/est)15.70%15.60%18.20%25.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.98-2.07-2.08-1.62
Actual EPS-2.33-2.25-2.23-1.52
Difference-0.35-0.18-0.150.1
Surprise %-17.70%-8.70%-7.20%6.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.75-1.64-6.44-5.02
7 days ago-1.76-1.64-6.45-4.97
30 days ago-1.76-1.63-6.44-4.96
60 days ago-1.76-1.63-6.43-4.79
90 days ago-1.65-1.57-6.18-4.36
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRAREIndustrySector(s)S&P 500
Current qtr.24.90%N/AN/AN/A
Next qtr.27.10%N/AN/AN/A
Current year21.90%N/AN/AN/A
Next year22.00%N/AN/AN/A
Next 5 years (per annum)8.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A